Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations.
Li P, Jia C, Fan Z, Hu X, Zhang W, Liu K, Sun S, Guo H, Yang N, Zhu M, Zhuang X, Xiao J, Zheng Z, Li S.
Li P, et al. Among authors: zhuang x.
Acta Pharm Sin B. 2023 Jun;13(6):2715-2735. doi: 10.1016/j.apsb.2023.01.014. Epub 2023 Jan 19.
Acta Pharm Sin B. 2023.
PMID: 37425039
Free PMC article.